GADD45A and hepatocellular carcinoma: Additionally, studies have shown that Aristolochic acids (AA) can inhibit ferroptosis through the p53/GADD45A/NRF2/SLC7A11 axis, promoting the growth of hepatocellular carcinoma [17].